Amit Sachdev, EVP Chief Patient & Ext Af Officer at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 6,382 shares at $421.77 ($2.7M) on 2024-02-21, disclosed to the SEC on 2024-02-23.
Scheduled sale ($2.7M) by EVP Chief Patient & Ext Af Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $421.77 | 3,191 | $1.3M | 50.0% |
| 2 | $421.77 | 3,191 | $1.3M | 50.0% |
| Total | $421.77 avg | 6,382 | $2.7M | 100% |
| Filing → |
| VRTX | SELL | 2024-05-17 | $14K | — | Filing → |
| VRTX | SELL | 2024-02-27 | $2.6M | — | Filing → |
| VRTX | SELL | 2024-02-21 | $3.6M | — | Filing → |